Assessment of inflammatory bowel disease risk prior to commencing IL-17 inhibitors: A cross sectional analysis of Irish practice

被引：0
|
作者：
Long, Amy [1 ]
Quigley, Claire [1 ]
Murphy, Lisa [1 ]
O'Gorman, Susan [1 ]
机构：
[1] St James Hosp, Dublin, Ireland
来源：
JEADV CLINICAL PRACTICE | 2025年 / 4卷 / 01期
关键词：
D O I：
10.1002/jvc2.579
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：308 / 310
页数：3
相关论文
共 50 条
  • [1] The IL-23/IL-17 pathway in inflammatory bowel disease
    Geremia, Alessandra
    Jewell, Derek P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (02) : 223 - 237
  • [2] IL-17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase
    Petitpain, Nadine
    D'Amico, Ferdinando
    Yelehe-Okouma, Melissa
    Jouzeau, Jean-Yves
    Netter, Patrick
    Peyrin-Biroulet, Laurent
    Gillet, Pierre
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 159 - 168
  • [3] IL-17 Links Autoimmune Pancreatitis to Inflammatory Bowel Disease
    Leppkes, Moritz
    Hirth, Sebastian
    Croxford, Andrew L.
    Waldner, Maximilian J.
    Waisman, Ari
    Neurath, Markus F.
    Becker, Christoph
    GASTROENTEROLOGY, 2011, 140 (05) : S127 - S127
  • [4] New Insights into the Role of IL-17 in Inflammatory Bowel Disease
    Noronha, Ansu Mammen
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (12) : 2180 - 2181
  • [5] Differential roles for IL-23 and IL-17 in inflammatory bowel disease
    Towne, J. E.
    Maxwell, J. R.
    Zhang, Y.
    Brown, W. A.
    Rottman, J. B.
    Budelsky, A. L.
    CYTOKINE, 2012, 59 (03) : 515 - 515
  • [6] Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
    Cristina-Sorina Cǎanǎ
    Ioana Berindan Neagoe
    Vasile Cozma
    Cristian Magdas
    Flaviu Tǎbǎan
    Dan Lucian Dumitrasu
    World Journal of Gastroenterology, 2015, (19) : 5823 - 5830
  • [7] Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
    Catana, Cristina-Sorina
    Neagoe, Ioana Berindan
    Cozma, Vasile
    Magdas, Cristian
    Tabaran, Flaviu
    Dumitrascu, Dan Lucian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5823 - 5830
  • [8] An Insight on the Possible Association between Inflammatory Bowel Disease and Biologic Therapy with IL-17 Inhibitors in Psoriasis Patients
    Orzan, Olguta Anca
    Tieranu, Cristian George
    Olteanu, Andrei Ovidiu
    Dorobantu, Alexandra Maria
    Cojocaru, Anca
    Mihai, Mara Madalina
    Popa, Liliana Gabriela
    Gheorghiu, Ana Maria
    Giurcaneanu, Calin
    Ion, Ana
    PHARMACEUTICS, 2023, 15 (08)
  • [9] Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease
    Verstockt, Bram
    Van Assche, Gert
    Vermeire, Severine
    Ferrante, Marc
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (01) : 31 - 47
  • [10] IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis
    Deng, Zhenzhen
    Wang, Shengfeng
    Wu, Cuifang
    Wang, Chunjiang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345